Search research articles
Contact Us
Filters
Showing results (401-410 of 531) with videos related to
Page
of 54
Sort By:
Pharmaceutics
|
November 27, 2021
Folate Functionalized Lipid Nanoparticles for Targeted Therapy of Methicillin-Resistant <i>Staphylococcus aureus</i>
Kushal Vanamala, Ketki Bhise, Hiram Sanchez, et al.
Open Forum Infectious Diseases
|
March 27, 2023
High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production
Ashlan J Kunz Coyne, Amer El Ghali, Kristen Lucas, et al.
Antimicrobial Agents and Chemotherapy
|
November 15, 2007
daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations
Warren E Rose, Steven N Leonard, George Sakoulas, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2003
Piperazinyl-linked fluoroquinolone dimers possessing potent antibacterial activity against drug-resistant strains of Staphylococcus aureus
Robert J Kerns, Michael J Rybak, Glenn W Kaatz, et al.
Antimicrobial Agents and Chemotherapy
|
June 14, 2021
<i>In Vitro</i> Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumannii
Jacinda C Abdul-Mutakabbir, Logan Nguyen, Philip T Maassen, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
October 19, 2018
Making the change to area under the curve-based vancomycin dosing
Emily L Heil, Kimberly C Claeys, Ryan P Mynatt, et al.
Antimicrobial Agents and Chemotherapy
|
April 17, 2019
Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection
Xiaoju Lv, Jeff Alder, Li Li, et al.
Infectious Diseases and Therapy
|
November 2, 2024
Heartfelt Impact: A Descriptive Analysis of Ceftaroline-Containing Regimens in Endocarditis due to Methicillin-Resistant Staphylococcus aureus
Kaylee E Caniff, Chloe Judd, Kristen Lucas, et al.
The Journal of Antimicrobial Chemotherapy
|
September 7, 2018
Averting the post-antibiotic era: successful use of meropenem/vaborbactam for carbapenem-resistant Serratia marcescens and Enterobacter aerogenes bacteraemia in a haemodialysis patient
Sarah C J Jorgensen, Philip McDonald, Ryan P Mynatt, et al.
Hospital Formulary
|
January 1, 1993
Roundtable discussion. Cost justification of innovative drugs through assessment of total health care costs
M J Rybak, R Allen, P C Craven, et al.
Page
of 54
Search research articles
Search
Showing results (401-410 of 531) with videos related to
Sort By:
Page
of 54
Pharmaceutics
|
November 27, 2021
Folate Functionalized Lipid Nanoparticles for Targeted Therapy of Methicillin-Resistant <i>Staphylococcus aureus</i>
Kushal Vanamala, Ketki Bhise, Hiram Sanchez, et al.
Open Forum Infectious Diseases
|
March 27, 2023
High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production
Ashlan J Kunz Coyne, Amer El Ghali, Kristen Lucas, et al.
Antimicrobial Agents and Chemotherapy
|
November 15, 2007
daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations
Warren E Rose, Steven N Leonard, George Sakoulas, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2003
Piperazinyl-linked fluoroquinolone dimers possessing potent antibacterial activity against drug-resistant strains of Staphylococcus aureus
Robert J Kerns, Michael J Rybak, Glenn W Kaatz, et al.
Antimicrobial Agents and Chemotherapy
|
June 14, 2021
<i>In Vitro</i> Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumannii
Jacinda C Abdul-Mutakabbir, Logan Nguyen, Philip T Maassen, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
October 19, 2018
Making the change to area under the curve-based vancomycin dosing
Emily L Heil, Kimberly C Claeys, Ryan P Mynatt, et al.
Antimicrobial Agents and Chemotherapy
|
April 17, 2019
Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection
Xiaoju Lv, Jeff Alder, Li Li, et al.
Infectious Diseases and Therapy
|
November 2, 2024
Heartfelt Impact: A Descriptive Analysis of Ceftaroline-Containing Regimens in Endocarditis due to Methicillin-Resistant Staphylococcus aureus
Kaylee E Caniff, Chloe Judd, Kristen Lucas, et al.
The Journal of Antimicrobial Chemotherapy
|
September 7, 2018
Averting the post-antibiotic era: successful use of meropenem/vaborbactam for carbapenem-resistant Serratia marcescens and Enterobacter aerogenes bacteraemia in a haemodialysis patient
Sarah C J Jorgensen, Philip McDonald, Ryan P Mynatt, et al.
Hospital Formulary
|
January 1, 1993
Roundtable discussion. Cost justification of innovative drugs through assessment of total health care costs
M J Rybak, R Allen, P C Craven, et al.
Page
of 54